Metagenomi Therapeutics, Inc.
MGX· Nasdaq
Metagenomi Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -7.69%
- Market cap
- $38.53M
- 37.78M shares
- Filings
- 154
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $25,210,000 | reported | |
| FY 2024 | 2024-12-31 | $52,295,000 | reported | |
| FY 2023 | 2023-12-31 | $44,756,000 | reported |
Metagenomi Therapeutics, Inc. · CIK 1785279 · Engraved from SEC EDGAR
